Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating botulinum toxin type A for neurogenic overactive bladder was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Overactive Bladder
• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 2 | Status: TERMINATED | Results posted: 2011-10-17